NCT01102426 2020-11-10
ADMYRE
PharmaMar
Phase 3 Completed
Clinical Trials
5 trialsNCT02100657 2020-10-12
Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
PharmaMar
Phase 1 Completed
NCT00884286 2018-04-25
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
PharmaMar
Phase 2 Completed
NCT00788099 2011-06-07
Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas
PharmaMar
Phase 1 Completed
NCT00229203 2009-12-24
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
PharmaMar
Phase 2 Completed